233 related articles for article (PubMed ID: 1711186)
21. Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.
Koopmans AE; Ober K; Dubbink HJ; Paridaens D; Naus NC; Belunek S; Krist B; Post E; Zwarthoff EC; de Klein A; Verdijk RM;
Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):6024-30. PubMed ID: 25159205
[TBL] [Abstract][Full Text] [Related]
22. In situ distribution of integrin alpha 2 beta 1 and alpha-actinin in melanocytic proliferations.
Duncan LM; Bouffard D; Howard C; Mihm MC; Byers HR
Mod Pathol; 1996 Sep; 9(9):938-43. PubMed ID: 8878027
[TBL] [Abstract][Full Text] [Related]
23. Current appraisal of conjunctival melanocytic tumors: classification and treatment.
Harooni H; Schoenfield LR; Singh AD
Future Oncol; 2011 Mar; 7(3):435-46. PubMed ID: 21417906
[TBL] [Abstract][Full Text] [Related]
24. PRAME immunohistochemistry is useful in the evaluation of conjunctival melanomas, nevi, and primary acquired melanosis.
LeBlanc RE; Miller DM; Zegans ME
J Cutan Pathol; 2021 Dec; 48(12):1442-1448. PubMed ID: 34089198
[TBL] [Abstract][Full Text] [Related]
25. Conjunctival melanocytic lesions in children.
McDonnell JM; Carpenter JD; Jacobs P; Wan WL; Gilmore JE
Ophthalmology; 1989 Jul; 96(7):986-93. PubMed ID: 2771364
[TBL] [Abstract][Full Text] [Related]
26. PRAME Expression in Junctional Melanocytic Proliferations of the Conjunctiva: A Potential Biomarker for Primary Acquired Melanosis/Conjunctival Melanocytic Intraepithelial Lesions.
Huang YY; Hrycaj SM; Chan MP; Stagner AM; Patel RM; Bresler SC
Am J Dermatopathol; 2022 Oct; 44(10):734-740. PubMed ID: 35475786
[TBL] [Abstract][Full Text] [Related]
27. [Immunohistochemical markers for cytoplasmic antigens in acquired melanosis, malignant melanomas, and nevi of the conjunctiva].
Hitzer S; Bialasiewicz AA; Richard G
Klin Monbl Augenheilkd; 1998 Oct; 213(4):230-7. PubMed ID: 9848068
[TBL] [Abstract][Full Text] [Related]
28. Ex vivo quality-switched ruby laser irradiation of cutaneous melanocytic lesions: persistence of S-100-, HMB-45- and Masson-positive cells.
Kopera D; Hohenleutner U; Stolz W; Landthaler M
Dermatology; 1997; 194(4):344-50. PubMed ID: 9252755
[TBL] [Abstract][Full Text] [Related]
29. Expression of sex hormone receptors and cell cycle proteins in melanocytic lesions of the ocular conjunctiva.
Pache M; Glatz-Krieger K; Sauter G; Meyer P
Graefes Arch Clin Exp Ophthalmol; 2006 Jan; 244(1):113-7. PubMed ID: 16003514
[TBL] [Abstract][Full Text] [Related]
30. SM5-1: a new monoclonal antibody which is highly sensitive and specific for melanocytic lesions.
Trefzer U; Rietz N; Chen Y; Audring H; Herberth G; Siegel P; Reinke S; Königer P; Wu S; Ma J; Liu Y; Wang H; Sterry W; Guo Y
Arch Dermatol Res; 2000 Dec; 292(12):583-9. PubMed ID: 11214818
[TBL] [Abstract][Full Text] [Related]
31. Immunoperoxidase technique modified by counterstain with azure B as a diagnostic aid in evaluating heavily pigmented melanocytic neoplasms.
Kamino H; Tam ST
J Cutan Pathol; 1991 Dec; 18(6):436-9. PubMed ID: 1723081
[TBL] [Abstract][Full Text] [Related]
32. Clinical and immunohistopathological study of conjunctival melanocytic lesions in pediatric and adolescent patients. A case series.
Bogdănici CM; Costea CF; Dumitrescu GF; Sava A; Ciobanu Apostol DG; Scripcariu DV; Nicoară SD; Tănase DM; Andriescu EC; Cărăuleanu A; Danciu M; Sălăvăstru SC; Schmitzer S; Cucu AI; Niagu IA
Rom J Morphol Embryol; 2021; 62(4):907-915. PubMed ID: 35673810
[TBL] [Abstract][Full Text] [Related]
33. Staining of melanocytic neoplasms by melanoma antigen recognized by T cells.
Mehregan DR; Hamzavi I
Am J Dermatopathol; 2000 Jun; 22(3):247-50. PubMed ID: 10871068
[TBL] [Abstract][Full Text] [Related]
34. Low-risk and high-risk histologic features in conjunctival primary acquired melanosis with atypia: Clinicopathologic analysis of 29 cases.
Sugiura M; Colby KA; Mihm MC; Zembowicz A
Am J Surg Pathol; 2007 Feb; 31(2):185-92. PubMed ID: 17255762
[TBL] [Abstract][Full Text] [Related]
35. Oral melanocytic lesions: differences in expression of HMB-45 and S-100 antigens in round and spindle cells of malignant and benign lesions.
Gazit D; Daniels TE
J Oral Pathol Med; 1994 Feb; 23(2):60-4. PubMed ID: 8164154
[TBL] [Abstract][Full Text] [Related]
36. Pediatric conjunctival melanoma arising from a compound nevus.
Liu KC; Mruthyunjaya P; Proia AD; Vora GK
J AAPOS; 2017 Oct; 21(5):416-418. PubMed ID: 28860029
[TBL] [Abstract][Full Text] [Related]
37. C-Kit SCF receptor (CD117) expression and KIT gene mutation in conjunctival pigmented lesions.
Alessandrini L; Parrozzani R; Bertorelle R; Valentini E; Candiotto C; Giacomelli L; Midena E; Blandamura S
Acta Ophthalmol; 2013 Dec; 91(8):e641-5. PubMed ID: 23742652
[TBL] [Abstract][Full Text] [Related]
38. Melanocytic activation in HIV-1 disease: HMB-45 staining in common acquired nevi. Military Medical Consortium for the Advancement of Retroviral Research.
Smith KJ; Skelton HG; Heimer W; Baxter D; Angritt P; Frisman D; Wagner KF
J Am Acad Dermatol; 1993 Oct; 29(4):539-44. PubMed ID: 7691905
[TBL] [Abstract][Full Text] [Related]
39. Usefulness of a red chromagen in the diagnosis of melanocytic lesions of the conjunctiva.
Jiang K; Brownstein S; Lam K; Burns B; Farmer J
JAMA Ophthalmol; 2014 May; 132(5):622-9. PubMed ID: 24626521
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes.
Gown AM; Vogel AM; Hoak D; Gough F; McNutt MA
Am J Pathol; 1986 May; 123(2):195-203. PubMed ID: 3518473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]